News
Prescription puppy, China’s commode hospital, Hall of Fame diuretics
And how sudden reverse-slope hearing loss endowed one woman with an extraordinary superpower.
News
NIH announces new clinical trial assessing FMT for recurrent CDAD
The trial will test the safety and efficacy of a standardized protocol with follow-up.
News
ICYMI: Caplacizumab benefits patients with acquired TTP
Treatment was associated with several benefits, including faster platelet normalization and a lower recurrence rate.
News
Torrent Pharmaceuticals expands losartan recall
Ten more lots recalled.
News
Gout’s Golden Globe, resistance is fecal, eucalyptus eulogy
You’ve met the in vivo and in vitro study. Please welcome the “in vimo” study!
News
Naltrexone/ketamine combo may reduce depressive symptoms in MDD/AUD patients
Depressive symptoms improved 57%-92% overall. In addition, four of the five patients reported improvement in alcohol craving and consumption.
News
White matter volume reduced in first-episode depression
The normalization of white matter might have been caused by treatment normalization or attributable to lack of study power, the investigators...
News
Bipolar patients’ ability to consent can be measured with MacCAT-CR
Some measures of the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR) were associated with lower levels of ability to give...
News
Early maladaptive schemas increase suicide risk, ideation in bipolar
“Providing social support in the economic, social, political, cultural, and educational spheres may be a factor in preventing suicide.”
News
ADHD more likely, causes worse outcomes in patients with BD
The lifetime ADHD prevalence rate of 24.6% in patients with bipolar disorder is significantly higher than the incidence in the general population...
News
FDA approves ravulizumab for treatment of paroxysmal nocturnal hemoglobinuria
The drug’s novel formulation means that patients can be treated every eight weeks, instead of every two weeks as is the case with the previously...
News
FDA reclassifies ECT devices for resistant depression, other conditions
Conditions included in the new order include treating catatonia or a severe major depressive episode associated with MDD or bipolar disorder in...
News
Guideline-concordant treatment still unlikely in nonchildren’s hospitals for pediatric CAP
This is concerning because the majority of children hospitalized with pneumonia are treated in nonchildren’s hospitals.
News
Positive results reported for ixekizumab versus adalimumab in PsA
Lilly described top-line results for the SPIRIT-H2H trial.